Point72 Asia (Singapore) Pte. Ltd. Shattuck Labs, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $646 Billion
- Q3 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 14,454 shares of STTK stock, worth $28,329. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,454
Previous 28,908
50.0%
Holding current value
$28,329
Previous $22.9 Million
50.92%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding STTK
# of Institutions
60Shares Held
38.6MCall Options Held
22.2KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA6.31MShares$12.4 Million0.5% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.31MShares$12.4 Million0.02% of portfolio
-
Redmile Group, LLC San Francisco, CA5.54MShares$10.9 Million1.42% of portfolio
-
Prosight Management, LP Dallas, TX5.45MShares$10.7 Million3.36% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$4.85 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $83.1M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...